Benecchi Christopher - Insider Non-Derivative Transactions at Sage Therapeutics, Inc. (SAGE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 5, 2024, Benecchi Christopher's relationship to Sage Therapeutics, Inc. (SAGE) is Officer (Chief Business Officer), and currently has 23,242 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SAGE insiders.
Data Source: SEC.
Benecchi Christopher - Insider Non-Derivative Transactions of SAGE Common Stock
Benecchi Christopher - Insider Non-Derivative Transactions at SAGE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 6, 2024 | F -- (Common Stock) | 4755 | 8.96 | 18487 |
| Aug 6, 2024 | Acquisition -- (Common Stock) | 16200 | 0 | 23242 |
| Feb 14, 2024 | Acquisition -- (Common Stock) | 13500 | 0 | 19430 |
| Feb 4, 2023 | F -- (Common Stock) | 2119 | 44.16 | 5260 |
| Feb 4, 2023 | Acquisition -- (Common Stock) | 6750 | 0 | 7379 |